Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Exicure Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
XCUR
Nasdaq
8731
https://www.exicuretx.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Exicure Inc
Exicure, Inc. Announces Support of CEO in its Ongoing Exploration of Strategic Alternatives
- May 26th, 2023 8:01 pm
Exicure, Inc. Received Nasdaq Delinquency Notice on Late Filing of its Form 10-Q
- May 19th, 2023 8:01 pm
Exicure, Inc. Announces Investment in Korean SNS Platform Cyworld
- May 4th, 2023 8:01 pm
Exicure, Inc. Announces Appointment of New CEO and CFO and Changes to Board of Directors
- Apr 27th, 2023 11:00 am
Exicure, Inc. Reports Full Year 2022 Financial Results and Provides Corporate Update
- Mar 27th, 2023 8:01 pm
Exicure, Inc. Announces Closing of Private Placement Transaction with CBI USA, Inc. and Changes to the Board of Directors
- Feb 24th, 2023 10:10 pm
Exicure, Inc. Announces Termination of AbbVie and Ipsen Collaboration Agreements
- Dec 14th, 2022 10:00 am
Exicure, Inc. Reports Third Quarter 2022 Financial Results and Provides Corporate Update
- Nov 14th, 2022 9:01 pm
Exicure, Inc. Enters Into Definitive Agreement With CBI USA, Inc. for $5.4 Million Equity Financing and Announces Implementation of Strategic Measure to Reduce Cash Burn and Prioritize Strategic Alternatives
- Sep 26th, 2022 8:01 pm
Exicure Announces Presentation at Chardan’s 6th Annual Genetic Medicines Conference
- Sep 1st, 2022 11:00 am
Exicure, Inc. Reports Second Quarter 2022 Financial Results and Corporate Progress
- Aug 15th, 2022 8:01 pm
Exicure, Inc. Regains Compliance with Nasdaq Minimum Bid Price Requirement
- Jul 20th, 2022 8:01 pm
Exicure, Inc. Announces Receipt of Nasdaq Notice of Non-compliance and Implementation of One-for-Thirty Reverse Stock Split
- Jun 29th, 2022 4:00 pm
Scroll